DE68903516C5 - Mittel zur Senkung des Blutdrucks. - Google Patents

Mittel zur Senkung des Blutdrucks. Download PDF

Info

Publication number
DE68903516C5
DE68903516C5 DE68903516.0T DE68903516T DE68903516C5 DE 68903516 C5 DE68903516 C5 DE 68903516C5 DE 68903516 T DE68903516 T DE 68903516T DE 68903516 C5 DE68903516 C5 DE 68903516C5
Authority
DE
Germany
Prior art keywords
void
composition according
blood pressure
lowering blood
molar ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68903516.0T
Other languages
English (en)
Other versions
DE68903516T2 (de
DE68903516D1 (de
Inventor
Raymond Mathieu Xhonneux
Guy Rosalia Eugene Van Lommen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68903516(C5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of DE68903516D1 publication Critical patent/DE68903516D1/de
Publication of DE68903516T2 publication Critical patent/DE68903516T2/de
Anticipated expiration legal-status Critical
Publication of DE68903516C5 publication Critical patent/DE68903516C5/de
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

nichtig

Description

  • Betreffend das europäische Patent 0 334 429 ( DE 689 03 516 )
    hat der 3. Senat (Nichtigkeitssenat) des Bundespatentgerichts auf Grund der mündlichen Verhandlung vom 18. März 2008 für Recht erkannt:
    • 1. Das europäische Patent EP 0 334 429 wird mit Wirkung für das Hoheitsgebiet der Bundesrepublik Deutschland teilweise für nichtig erklärt, soweit es über Patentanspruch 5, Patentansprüche 7 bis 8 in ihrer Rückbeziehung auf Patentanspruch 5 sowie Patentanspruch 13 in seiner Rückbeziehung auf Patentansprüche 7 und 8, soweit diese wiederum auf Patentanspruch 5 rückbezogen sind, hinausgeht.

Claims (14)

  1. nichtig
  2. nichtig
  3. nichtig
  4. nichtig
  5. Zusammensetzung nach Anspruch 4, worin das blutdrucksenkende Mittel unter Atenolol, Propranolol, Metoprolol, Prazosin, Hydralazin, Guanethidin, Phentolamin, Verapamil, Nifedipin, Carteolol und Celiprolol ausgewählt ist.
  6. nichtig
  7. Zusammensetzung nach Anspruch 5 oder 6, worin das Molverhältnis der beiden wirksamen Bestandteile 1:1 beträgt.
  8. Zusammensetzung nach Anspruch 5 oder 6, worin das Molverhältnis der beiden wirksamen Bestandteile von 1:1 verschieden ist.
  9. nichtig
  10. nichtig
  11. nichtig
  12. nichtig
  13. Verfahren zur Herstellung einer Zusammensetzung nach den Ansprüchen 4 bis 8 und 12, dadurch gekennzeichnet, daß der wirksame Bestandteil oder die wirksamen Bestandteile innig mit dem pharmazeutischen Träger vermischt wird oder werden.
  14. nichtig
DE68903516.0T 1988-03-23 1989-03-16 Mittel zur Senkung des Blutdrucks. Expired - Lifetime DE68903516C5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17274788A 1988-03-23 1988-03-23
US172747 1988-03-23

Publications (3)

Publication Number Publication Date
DE68903516D1 DE68903516D1 (de) 1992-12-24
DE68903516T2 DE68903516T2 (de) 1993-04-01
DE68903516C5 true DE68903516C5 (de) 2017-07-13

Family

ID=22629045

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1996175037 Pending DE19675037I1 (de) 1988-03-23 1989-03-16 Mittel zur Senkung des Blutdrucks
DE68903516.0T Expired - Lifetime DE68903516C5 (de) 1988-03-23 1989-03-16 Mittel zur Senkung des Blutdrucks.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE1996175037 Pending DE19675037I1 (de) 1988-03-23 1989-03-16 Mittel zur Senkung des Blutdrucks

Country Status (19)

Country Link
EP (1) EP0334429B1 (de)
JP (1) JPH0637487B2 (de)
KR (1) KR970011287B1 (de)
AU (1) AU621591B2 (de)
CA (1) CA1337432C (de)
CY (1) CY1802A (de)
DE (2) DE19675037I1 (de)
DK (1) DK174422B1 (de)
ES (1) ES2052881T3 (de)
GR (1) GR3006972T3 (de)
HK (1) HK123594A (de)
HU (1) HU211539A9 (de)
IE (1) IE62159B1 (de)
IL (1) IL89691A (de)
LU (1) LU88842I2 (de)
NL (1) NL950031I2 (de)
NZ (1) NZ228321A (de)
PT (1) PT90095B (de)
ZA (1) ZA892179B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
CA2207333C (en) * 1994-12-28 2006-10-17 Janssen Pharmaceutica, Naamloze Vennootschap Use of nebivolol as an anti-atherogenic
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5663194A (en) * 1995-07-25 1997-09-02 Mewshaw; Richard E. Chroman-2-ylmethylamino derivatives
US5684039A (en) * 1995-07-25 1997-11-04 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5670667A (en) * 1995-07-25 1997-09-23 American Home Products Corporation Chroman-2-ylmethylamino derivatives
ATE457169T1 (de) 1998-10-15 2010-02-15 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
DE60233140D1 (de) 2001-05-02 2009-09-10 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
RU2378272C2 (ru) 2004-07-30 2010-01-10 Торрент Фармасьютикалз Лимитед Небиволол и его фармацевтически приемлемые соли, способ их получения и фармацевтические композиции небиволола
ATE465157T1 (de) * 2004-08-11 2010-05-15 Hetero Drugs Ltd Neues verfahren zur herstellung von nebivololzwischenprodukten
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
US20070014734A1 (en) * 2005-01-31 2007-01-18 O'donnell John P Glucuronidated nebivolol metabolites
JP2008528626A (ja) * 2005-01-31 2008-07-31 マイラン ラボラトリーズ インク． ヒドロキシル化されたネビボロールを含む薬学的組成物
CN100546987C (zh) * 2005-03-03 2009-10-07 浙江医药股份有限公司新昌制药厂 Dl-奈必洛尔及其盐酸盐的制备方法
US7560575B2 (en) 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (de) * 2005-12-28 2012-07-25 Acino Pharma AG Ein Verfahren zur Herstellung von racemischem Nebivolol
WO2007083318A1 (en) 2006-01-18 2007-07-26 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
PL2228374T3 (pl) * 2006-11-27 2013-11-29 Zach System Spa Mrówczan nebiwololu
SI2102196T1 (sl) * 2006-11-27 2012-12-31 Zach System S.P.A. Postopek za pripravo nebivolola
GB0624282D0 (en) 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
WO2008089549A1 (en) 2007-01-22 2008-07-31 Genpharm Ulc Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
CN101531651B (zh) * 2008-03-13 2011-05-04 四川大学 光学活性3,4-二氢-2h-1-苯并吡喃-2-羧酸和3,4-二氢-4-氧-2h-1-苯并吡喃-2-羧酸类化合物的制备方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
US8785664B2 (en) 2010-02-11 2014-07-22 Menarini International Operations Luxembourg S.A. Process for the preparation of nebivolol
IT1397962B1 (it) * 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) * 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
WO2014111903A2 (en) 2013-01-21 2014-07-24 Cadila Pharmaceuticals Limited A process for the preparation of 6-fluoro-3,4-dihydro-2h-chromene- 2-carbaldehyde
EP2907809B1 (de) 2014-02-14 2018-08-22 Corden Pharma International GmbH Verfahren zur basenlosen Herstellung von Ketonzwischenprodukten zur Herstellung von Nebivolol
EP2907810A1 (de) 2014-02-14 2015-08-19 Corden Pharma International GmbH Neues Verfahren zur Herstellung von hochreinem Nebivolol-Hydrochlorid
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
PL3299364T3 (pl) 2015-05-19 2022-02-07 Zhejiang Ausun Pharmaceutical Co., Ltd. Sposób syntezy nebiwololu i jego związek pośredni
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
ITUB20160227A1 (it) 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol

Also Published As

Publication number Publication date
EP0334429A1 (de) 1989-09-27
NZ228321A (en) 1991-02-26
IE62159B1 (en) 1994-12-28
NL950031I1 (de) 1996-02-01
GR3006972T3 (de) 1993-06-30
CA1337432C (en) 1995-10-24
AU621591B2 (en) 1992-03-19
DE68903516T2 (de) 1993-04-01
PT90095B (pt) 1994-11-30
LU88842I2 (fr) 1997-01-27
DK146289D0 (da) 1989-03-22
DE68903516D1 (de) 1992-12-24
CY1802A (en) 1995-02-17
ES2052881T3 (es) 1994-07-16
KR890014510A (ko) 1989-10-24
HU211539A9 (en) 1995-12-28
AU3074289A (en) 1989-09-28
DE19675037I1 (de) 2003-09-04
KR970011287B1 (ko) 1997-07-09
HK123594A (en) 1994-11-18
DK174422B1 (da) 2003-02-24
PT90095A (pt) 1989-11-10
JPH0637487B2 (ja) 1994-05-18
IL89691A0 (en) 1989-09-28
DK146289A (da) 1989-09-24
NL950031I2 (nl) 1997-01-06
JPH01283220A (ja) 1989-11-14
IL89691A (en) 1994-04-12
IE890906L (en) 1989-09-23
ZA892179B (en) 1990-11-28
EP0334429B1 (de) 1992-11-19

Similar Documents

Publication Publication Date Title
DE68903516C5 (de) Mittel zur Senkung des Blutdrucks.
Stenvik et al. Pulp and dentine reactions to experimental tooth intrusion: a histologic study of the initial changes
DE3778244D1 (de) Oestradiol-implantat und verfahren zu seiner herstellung.
DE03014533T1 (de) Prostaglandinderivative zur Behandlung von Glaukom oder okuläre Hypertension
CA2125579A1 (en) Ulcer prevention treatment composition and method
CA2337750A1 (en) Therapeutic or cosmetic compositions containing dimeric or polymeric forms of hydroxyacids, and their therapeutic use
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
NZ229426A (en) (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile, its pharmaceutical compositions and intermediates for its preparations
CA2003422A1 (en) Quinuclidines, their use as medicaments and processes for their preparation
CA2016659A1 (en) Stabilized compositions containing epidermal growth factor
GR3032397T3 (en) Novel bisphosphines for asymetric hydrogenation catalysts.
EP0322779A3 (de) Benzolaktam-Verbindungen und deren pharmazeutische Verwendungen
DE3862044C5 (de) Verfahren zur Herstellung von zahnradgekräuselten Metallfasern und diese Fasern enthaltende Produkte.
GB8810173D0 (en) Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer
EP0327709A3 (de) Platin-Komplex, diesen enthaltendes antineoplastisches Agens, Zwischenprodukt, Verfahren zur Herstellung und Verwendung
ZA878182B (en) Enhancement of prazosin
IT1180575B (it) Divaricatore operativo odontoiatrico
EP0162715A3 (en) Enzyme-inhibitory griseolic acid derivatives, and their use
ATE141773T1 (de) Behandlungssystem zur anwendung in der funktionalen orthodontie
ATE58723T1 (de) Verfahren zur herstellung von c1- bis c6-nalkylpyrrolidonen aus bernsteinsaeureanhydrid bzw. c1- bis c6-n-alkylsuccinimid.
IN166819B (de)
DE69924741D1 (de) Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur vorbeugung und behandlung von parodontitis
CA1325901C (en) Antibiotic alloys
JPS5621559A (en) Nontacky chewing gum and its preparation
DE3853926D1 (de) 2-Oxa-isocephem-Verbindungen, diese enthaltende Zusammensetzungen und Verfahren zur Herstellung dieser Verbindungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition